These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO _____________
|
|
|
Commission File Number:
001-12421
|
|
|
|
NU SKIN ENTERPRISES, INC.
|
||||
|
(Exact name of registrant as specified in its charter)
|
||||
|
Delaware
|
87-0565309
|
|||
|
(State or other jurisdiction of incorporation or organization)
|
75 WEST CENTER STREET
PROVO UT 84601
|
(IRS Employer Identification No.)
|
||
|
(Address of principal executive offices, including zip code)
|
||||
|
(801) 345-1000
|
||||
|
(Registrant’s telephone number, including area code)
|
||||
|
Page
|
||||
|
Part I.
|
Financial Information
|
|||
|
Item 1.
|
Financial Statements (Unaudited):
|
|||
|
Consolidated Balance Sheets
|
1
|
|||
|
Consolidated Statements of Income
|
2
|
|||
|
Consolidated Statements of Cash Flows
|
3
|
|||
|
Notes to Consolidated Financial Statements
|
4
|
|||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
11
|
||
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
25
|
||
|
Item 4.
|
Controls and Procedures
|
25
|
||
|
Part II.
|
Other Information
|
|||
|
Item 1.
|
Legal Proceedings
|
26
|
||
|
Item 1A.
|
Risk Factors
|
26
|
||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
26
|
||
|
Item 6.
|
Exhibits
|
27
|
||
|
Signature
|
28
|
|||
|
March 31,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 180,136 | $ | 158,045 | ||||
|
Accounts receivable
|
22,406 | 22,513 | ||||||
|
Inventories, net
|
114,473 | 105,661 | ||||||
|
Prepaid expenses and other
|
53,163 | 51,724 | ||||||
| 370,178 | 337,943 | |||||||
|
Property and equipment, net
|
80,308 | 79,356 | ||||||
|
Goodwill
|
112,446 | 112,446 | ||||||
|
Other intangible assets, net
|
80,588 | 81,968 | ||||||
|
Other assets
|
127,290 | 136,736 | ||||||
|
Total assets
|
$ | 770,810 | $ | 748,449 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 28,979 | $ | 25,292 | ||||
|
Accrued expenses
|
132,058 | 124,520 | ||||||
|
Current portion of long-term debt
|
41,487 | 35,400 | ||||||
| 202,524 | 185,212 | |||||||
|
Long-term debt
|
114,653 | 121,119 | ||||||
|
Other liabilities
|
55,966 | 66,431 | ||||||
|
Total liabilities
|
373,143 | 372,762 | ||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Class A common stock – 500 million shares authorized, $.001
par value, 90.6 million shares issued
|
91 | 91 | ||||||
|
Additional paid-in capital
|
240,658 | 232,219 | ||||||
|
Treasury stock, at cost – 27.9 million and 27.8 million shares
|
(442,077 | ) | (433,567 | ) | ||||
|
Retained earnings
|
668,329 | 645,078 | ||||||
|
Accumulated other comprehensive loss
|
(69,334 | ) | (68,134 | ) | ||||
| 397,667 | 375,687 | |||||||
|
Total liabilities and stockholders’ equity
|
$ | 770,810 | $ | 748,449 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Revenue
|
$ | 364,124 | $ | 296,198 | ||||
|
Cost of sales
|
64,833 | 53,806 | ||||||
|
Gross profit
|
299,291 | 242,392 | ||||||
|
Operating expenses:
|
||||||||
|
Selling expenses
|
154,262 | 124,499 | ||||||
|
General and administrative expenses
|
98,912 | 88,356 | ||||||
|
Restructuring charges
|
─
|
9,386 | ||||||
|
Total operating expenses
|
253,174 | 222,241 | ||||||
|
Operating income
|
46,117 | 20,151 | ||||||
|
Other income (expense), net
|
614 | (1,236 | ) | |||||
|
Income before provision for income taxes
|
46,731 | 18,915 | ||||||
|
Provision for income taxes
|
15,691 | 7,074 | ||||||
|
Net income
|
$ | 31,040 | $ | 11,841 | ||||
|
Net income per share (Note 2):
|
||||||||
|
Basic
|
$ | 0.50 | $ | 0.19 | ||||
|
Diluted
|
$ | 0.48 | $ | 0.19 | ||||
|
Weighted-average common shares outstanding (000s):
|
||||||||
|
Basic
|
62,474 | 63,334 | ||||||
|
Diluted
|
64,767 | 63,522 | ||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 31,040 | $ | 11,841 | ||||
|
Adjustments to reconcile net income to net cash
|
||||||||
|
provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
7,288 | 7,409 | ||||||
|
Foreign currency (gains)/losses
|
(1,136 | ) | (640 | ) | ||||
|
Stock-based compensation
|
2,032 | 2,107 | ||||||
|
Deferred taxes
|
862 | 900 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(116 | ) | (4,215 | ) | ||||
|
Inventories, net
|
(8,375 | ) | (553 | ) | ||||
|
Prepaid expenses and other
|
(1,900 | ) | 1,338 | |||||
|
Other assets
|
(2,508 | ) | (594 | ) | ||||
|
Accounts payable
|
2,530 | (1,001 | ) | |||||
|
Accrued expenses
|
8,594 | 2,957 | ||||||
|
Other liabilities
|
673 | (875 | ) | |||||
|
Net cash provided by operating activities
|
38,984 | 18,674 | ||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property and equipment
|
(6,720 | ) | (3,185 | ) | ||||
|
Net cash used in investing activities
|
(6,720 | ) | (3,185 | ) | ||||
|
Cash flows from financing activities:
|
||||||||
|
Exercise of employee stock options
|
5,301 | 3 | ||||||
|
Payment of cash dividends
|
(7,789 | ) | (7,286 | ) | ||||
|
Income tax benefit of options exercised
|
2,401 |
─
|
||||||
|
Repurchases of shares of common stock
|
(10,149 | ) | (2,001 | ) | ||||
|
Net cash used in financing activities
|
(10,236 | ) | (9,284 | ) | ||||
|
Effect of exchange rate changes on cash
|
63 | (3,757 | ) | |||||
|
Net increase in cash and cash equivalents
|
22,091 | 2,448 | ||||||
|
Cash and cash equivalents, beginning of period
|
158,045 | 114,586 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 180,136 | $ | 117,034 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Net income
|
$ | 31,040 | $ | 11,841 | ||||
|
Other comprehensive income, net of tax:
|
||||||||
|
Foreign currency translation adjustment
|
(1,103 | ) | 110 | |||||
|
Net unrealized losses on foreign
currency cash flow hedges
|
29 |
─
|
||||||
|
Less: Reclassification adjustment for realized
losses (gains) in current earnings
|
(126 | ) |
─
|
|||||
|
Comprehensive income
|
$ | 29,840 | $ | 11,951 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
Revenue:
|
2010
|
2009
|
||||||
|
North Asia
|
$ | 170,861 | $ | 139,818 | ||||
|
Americas
|
62,454 | 58,416 | ||||||
|
Greater China
|
57,685 | 47,470 | ||||||
|
Europe
|
37,780 | 26,674 | ||||||
|
South Asia/Pacific
|
35,344 | 23,820 | ||||||
|
Total
|
$ | 364,124 | $ | 296,198 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
Revenue:
|
2010
|
2009
|
||||||
|
Nu Skin
|
$ | 223,266 | $ | 163,203 | ||||
|
Pharmanex
|
138,116 | 129,936 | ||||||
|
Other
|
2,742 | 3,059 | ||||||
|
Total
|
$ | 364,124 | $ | 296,198 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
Revenue:
|
2010
|
2009
|
||||||
|
Japan
|
$ | 108,693 | $ | 109,884 | ||||
|
United States
|
53,042 | 49,236 | ||||||
|
South Korea
|
62,168 | 29,934 | ||||||
|
Europe
|
31,365 | 22,819 | ||||||
|
Taiwan
|
24,143 | 19,287 | ||||||
|
Mainland China
|
20,381 | 16,452 | ||||||
|
Long-lived assets:
|
March 31,
2010
|
December 31, 2009
|
||||||
|
Japan
|
$ | 8,133 | $ | 8,079 | ||||
|
United States
|
42,995 | 42,378 | ||||||
|
South Korea
|
3,689 | 3,654 | ||||||
|
Europe
|
2,727 | 3,005 | ||||||
|
Taiwan
|
2,153 | 1,758 | ||||||
|
Mainland China
|
11,182 | 11,841 | ||||||
|
Facility or
Arrangement
(1)
|
Original Principal Amount
|
Balance as of
March 31, 2010
(2)
|
Interest Rate
|
Repayment terms
|
||||
|
2000 Japanese yen- denominated notes
|
9.7 billion yen
|
1.4 billion yen ($14.8 million as of March 31, 2010)
|
3.0%
|
Notes due October 2010, with annual principal payments that began in October 2004.
|
||||
|
2003 - 2009 $205.0 million multi-currency uncommitted shelf facility:
|
||||||||
|
U.S. dollar-
denominated:
|
$50.0 million
|
$10.0 million
|
4.5%
|
Notes due April 2010, with annual principal payments that began in April 2006.
|
||||
|
$40.0 million
|
$40.0 million
|
6.2%
|
Notes due July 2016, with annual principal payments that begin in July 2010.
|
|||||
|
$20.0 million
|
$20.0 million
|
6.2%
|
Notes due January 2017, with annual principal payments beginning January 2011.
|
|||||
|
Japanese yen-
denominated:
|
3.1 billion yen
|
2.2 billion yen ($23.8 million as of March 31, 2010)
|
1.7%
|
Notes due April 2014, with annual principal payments that began in April 2008.
|
||||
|
2.3 billion yen
|
2.3 billion yen ($24.3 million as of March 31, 2010)
|
2.6%
|
Notes due September 2017, with annual principal payments beginning September 2011.
|
|||||
|
2.2 billion yen
|
2.2 billion yen ($23.2 million as of March 31, 2010)
|
3.3%
|
Notes due January 2017, with annual principal payments beginning January 2011.
|
|||||
|
2004 $25.0 million revolving credit facility
|
N/A
|
None
|
N/A
|
Credit facility expires May 2011.
|
||||
|
2009 $100.0 million uncommitted multi-currency shelf facility
|
N/A
|
None
|
N/A
|
|
(1)
|
Each of the credit facilities and arrangements listed in the table are secured by guarantees issued by the Company’s material domestic subsidiaries and by pledges of 65% of the outstanding stock of the Company’s material foreign subsidiaries.
|
|
(2)
|
The current portion of the Company’s long-term debt (i.e. becoming due in the next 12 months) is $41.5 million and includes $14.8 million of the balance on the Company’s 2000 Japanese yen- denominated notes, $8.1 million of the balance of the Company’s Japanese yen-denominated notes and $18.6 million of the balance on the Company’s U.S. dollar-denominated debt under the 2003 multi-currency shelf facility.
|
|
2010
|
2009
|
Change
|
||||||||||
|
Japan
|
$ | 108.7 | $ | 109.9 | (1%) | |||||||
|
South Korea
|
62.2 | 29.9 | 108% | |||||||||
|
North Asia total
|
$ | 170.9 | $ | 139.8 | 22% | |||||||
|
2010
|
2009
|
Change
|
||||||||||
|
United States
|
$ | 53.1 | $ | 49.2 | 8% | |||||||
|
Canada
|
6.0 | 4.6 | 30% | |||||||||
|
Latin America
|
3.4 | 4.6 | (26%) | |||||||||
|
Americas total
|
$ | 62.5 | $ | 58.4 | 7% | |||||||
|
2010
|
2009
|
Change
|
||||||||||
|
Taiwan
|
$ | 24.1 | $ | 19.3 | 25% | |||||||
|
Mainland China
|
20.4 | 16.5 | 24% | |||||||||
|
Hong Kong
|
13.2 | 11.7 | 13% | |||||||||
|
Greater China total
|
$ | 57.7 | $ | 47.5 | 22% | |||||||
|
2010
|
2009
|
Change
|
||||||||||
|
Europe
|
$ | 37.8 | $ | 26.7 | 42% | |||||||
|
2010
|
2009
|
Change
|
||||||||||
|
Singapore/Malaysia/Brunei
|
$ | 13.6 | $ | 9.4 | 45% | |||||||
|
Thailand
|
12.0 | 8.0 | 50% | |||||||||
|
Australia/New Zealand
|
4.5 | 2.7 | 67% | |||||||||
|
Indonesia
|
3.0 | 2.0 | 50% | |||||||||
|
Philippines
|
2.2 | 1.7 | 29% | |||||||||
|
South Asia/Pacific total
|
$ | 35.3 | $ | 23.8 | 48% | |||||||
|
|
•
|
purchases of computer systems and software, including equipment and development costs;
|
|
|
•
|
the build-out and upgrade of leasehold improvements in our various markets, including retail stores in China; and
|
|
Facility or
Arrangement
(1)
|
Original Principal Amount
|
Balance as of
March 31, 2010
(2)
|
Interest Rate
|
Repayment terms
|
||||
|
2000 Japanese yen- denominated notes
|
9.7 billion yen
|
1.4 billion yen ($14.8 million as of March 31, 2010)
|
3.0%
|
Notes due October 2010, with annual principal payments that began in October 2004.
|
||||
|
2003 – 2009 $205.0 million multi-currency uncommitted shelf facility:
|
||||||||
|
U.S. dollar-
denominated:
|
$50.0 million
|
$10.0 million
|
4.5%
|
Notes due April 2010, with annual principal payments that began in April 2006.
|
||||
|
$40.0 million
|
$40.0 million
|
6.2%
|
Notes due July 2016, with annual principal payments that begin in July 2010.
|
|||||
|
$20.0 million
|
$20.0 million
|
6.2%
|
Notes due January 2017, with annual principal payments beginning January 2011.
|
|||||
|
Japanese yen-
denominated:
|
3.1 billion yen
|
2.2 billion yen ($23.8 million as of March 31, 2010)
|
1.7%
|
Notes due April 2014, with annual principal payments that began in April 2008.
|
||||
|
2.3 billion yen
|
2.3 billion yen ($24.3 million as of March 31, 2010)
|
2.6%
|
Notes due September 2017, with annual principal payments beginning September 2011.
|
|||||
|
2.2 billion yen
|
2.2 billion yen ($23.2 million as of March 31, 2010)
|
3.3%
|
Notes due January 2017, with annual principal payments beginning January 2011.
|
|||||
|
2004 $25.0 million revolving credit facility
|
N/A
|
None
|
N/A
|
Credit facility expires May 2011.
|
||||
|
2009 $100.0 million uncommitted multi-currency shelf facility
|
N/A
|
None
|
N/A
|
|
(1)
|
Each of the credit facilities and arrangements listed in the table are secured by guarantees issued by the Company’s material domestic subsidiaries and by pledges of 65% of the outstanding stock of the Company’s material foreign subsidiaries.
|
|
(2)
|
The current portion of our long-term debt (i.e. becoming due in the next 12 months) is $41.5 million and includes $14.8 million of the balance on our 2000 Japanese yen-denominated notes, $8.1 million of the balance of our Japanese yen-denominated notes and $18.6 million of the balance on our U.S. dollar-denominated debt under the 2003 multi-currency shelf facility.
|
|
|
•
|
the nature of any restrictions on the transferor’s assets that relate to a transferred financial asset, including the carrying amount of those assets;
|
| As of March 31, 2010 | As of March 31, 2009 | ||||||
|
Region:
|
Active
|
Executive
|
Active
|
Executive
|
|||
|
North Asia
|
319,000
|
14,842
|
319,000
|
13,971
|
|||
|
Americas
|
167,000
|
5,481
|
171,000
|
4,993
|
|||
|
Greater China
|
108,000
|
7,155
|
99,000
|
5,972
|
|||
|
Europe
|
99,000
|
3,551
|
85,000
|
2,850
|
|||
|
South Asia/Pacific
|
72,000
|
3,040
|
63,000
|
2,368
|
|||
|
Total
|
765,000
|
34,069
|
737,000
|
30,154
|
|||
|
|
•
|
our plans and expectations regarding our initiatives, strategies, development and launch of new products, and other innovation efforts;
|
|
|
•
|
our anticipation regarding the amount and uses of capital expenditures for 2010;
|
|
|
•
|
our anticipation regarding the declaration and funding of future quarterly cash dividends;
|
|
|
•
|
our beliefs and plans regarding our liquidity, cash balances and cash flows from operations;
|
|
|
•
|
our beliefs regarding our Japan customs matters;
|
|
|
•
|
our expectations and beliefs regarding critical accounting policies and recent accounting pronouncements;
|
|
|
•
|
our belief that we have appropriately provided for income taxes for all years; and
|
|
|
•
|
our expectations regarding the impact of foreign currency fluctuations and our efforts to reduce our exposure to such fluctuations.
|
|
•
|
continued or increased levels of regulatory and media scrutiny and any regulatory actions taken by regulators, or any adoption of more restrictive regulations, in response to such scrutiny;
|
|
•
|
any weakening of the Japanese yen;
|
|
•
|
regulatory constraints with respect to the claims we can make regarding the efficacy of products and tools, which could limit our ability to effectively market them;
|
|
•
|
risks that the new initiatives we are implementing in Japan, which are patterned after successful initiatives implemented in other markets, will not have the same level of success in Japan, may not generate renewed growth or increased productivity among our distributors, and may cost more or require more time to implement than we have anticipated;
|
|
•
|
inappropriate activities by our distributors and any resulting regulatory actions;
|
|
•
|
any increased weakness in the economy or consumer confidence; and
|
|
•
|
increased competitive pressures from other direct selling companies and their distributors who actively seek to solicit our distributors to join their businesses.
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
|
(a)
|
(b)
|
(c)
|
(d)
|
|||||
|
Period
|
Total Number of Shares Purchased
|
Average Price Paid per Share
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
(in millions)
(1)
|
||||
|
January 1 – 31, 2010
|
295,000
|
$ 25.45
|
295,000
|
$ 55.0
|
||||
|
February 1 – 28, 2010
|
105,537
|
$ 24.93
|
105,000
|
$ 52.4
|
||||
|
March 1 – 31, 2010
|
0
|
N/A
|
0
|
$ 52.4
|
||||
|
Total
|
400,537
|
(2) |
|
|
(1)
|
In August 1998, our board of directors approved a plan to repurchase $10.0 million of our Class A common stock on the open market or in private transactions. Our board has from time to time increased the amount authorized under the plan and a total amount of approximately $335.0 million is currently authorized. As of March 31, 2010, we had repurchased approximately $282.6 million of shares under the plan. There has been no termination or expiration of the plan since the initial date of approval.
|
|
(2)
|
We have authorized the repurchase of shares acquired by our employees and distributors in certain foreign markets because of regulatory and other issues that make it difficult or costly for these persons to sell such shares in the open market. These shares were awarded or acquired in connection with our initial public offering in 1996. Of the shares listed in this column, 537 relate to repurchases from such employees and distributors at an average price per share of $26.13.
|
|
ITEM 6.
|
EXHIBITS
|
|
10.1
|
Performance Targets and Formulas for 2010.
|
|
31.1
|
Certification by M. Truman Hunt, President and Chief Executive Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes–Oxley Act of 2002.
|
|
31.2
|
Certification by Ritch N. Wood, Chief Financial Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
|
Certification by M. Truman Hunt, President and Chief Executive Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
Certification by Ritch N. Wood, Chief Financial Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
SIGNATURE
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
NU SKIN ENTERPRISES, INC.
|
|||
|
|
By:
|
/s/ Ritch N. Wood | |
| Ritch N. Wood | |||
| Its: |
Chief Financial Officer
(Duly Authorized Officer and Principal Financial and Accounting Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|